Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer - Wikidata - wikimedia - TriplyDB

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

http://www.wikidata.org/entity/Q35079280

about

BRAF activates and physically interacts with PAK to regulate cell motility

P2860

Q28248127-07A2BD09-12FB-49EA-9645-ED4DD3FFA677

P2860

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

http://www.wikidata.org/entity/Q35079280

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@ast

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@en

type

label

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@ast

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@en

prefLabel

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@ast

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@en

P1433

Q35079280-B5C87875-B8D5-4063-8D2D-4CBC75991D7D

P1476

Q35079280-93519BD4-1402-469C-9125-1E08A1DEFEC7

P2093

Q35079280-15A6E825-D4F7-45D7-BC4B-3B75CD06BF47

Q35079280-27F8AFC8-50EC-4645-AF01-946FA3520D77

Q35079280-2857766E-E37A-4B72-9902-E4CAAE51B297

Q35079280-348235B5-AD01-4FC0-8C2C-BD9F18785929

Q35079280-50A10A5B-1334-4C52-B099-F548152A00D6

Q35079280-801C14BF-372E-4D0E-928E-AEED1861C61F

Q35079280-BE8DF9B8-6C34-4721-BF13-06B89849AD2D

Q35079280-D07087CC-2DBC-48F0-A8B4-ECAD64601FA6

Q35079280-DB4DF631-1E1E-434F-B84A-977F54D27880

Q35079280-EE94C686-3729-49D5-AC3F-08DF450B9CBE

P2860

Q35079280-082AEABC-E5CB-45F5-95B8-CF243A8064D7

Q35079280-0D78A6E3-705A-48BD-B344-A6FC528819C0

Q35079280-104B09D3-3F48-40C4-B075-BAD709206602

Q35079280-27AB48C1-0F9D-47D3-BA34-3DFF4F5F76AB

Q35079280-36B60D98-452D-4CBA-8BB2-6D893BB3A57C

Q35079280-3E5EEC90-F197-4E0E-A09D-72DC206F3048

Q35079280-3E665AC9-AEBC-4411-A73E-E7D95A5A930F

Q35079280-485094AA-F1D1-4B53-B75F-9C471912B073

Q35079280-612B21B5-A9E2-4698-B5D9-93E2E79694A1

Q35079280-722896CC-FC45-4888-9468-3B3D908CAB6A

P304

Q35079280-9162960C-9EC0-4D3D-8545-D83D56A1BD5A

P31

Q35079280-832E962B-213D-4F9D-885D-6C84490D4E47

P356

Q35079280-E8858D5F-C428-4A91-BB59-8D015BE3AAAB

P407

Q35079280-6C744C5C-F9AA-4783-B9B7-2AC8FF87E9A3

P433

Q35079280-DB332ACA-6C70-4E4C-95D6-F029B7E5B13F

P478

Q35079280-4C56ABD2-FE98-47F9-BDFB-299C6319A8F4

P50

Q35079280-4CA06DD6-2A08-47A4-B17F-A968B2901DBB

P577

Q35079280-919C776C-499D-4FE5-8BCC-F5585BED13CB

P698

Q35079280-5C9630B2-343A-42F1-9CC0-2DFD4A1B79AE

P932

Q35079280-151FEEDA-0055-430C-8D83-6D5AE5ECFFBD

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Localization of CaSR antagonists in CaSR-expressing medullary thyroid cancer

@en

P2093

Adlina Mohd Yusof

http://www.w3.org/2001/XMLSchema#string

Chaojie Wang

http://www.w3.org/2001/XMLSchema#string

Haiming Ding

http://www.w3.org/2001/XMLSchema#string

Keisha Milum

http://www.w3.org/2001/XMLSchema#string

Krishan Kumar

http://www.w3.org/2001/XMLSchema#string

Matthew D Ringel

http://www.w3.org/2001/XMLSchema#string

Michael F Tweedle

http://www.w3.org/2001/XMLSchema#string

Michelle Carleton

http://www.w3.org/2001/XMLSchema#string

Motoyasu Saji

http://www.w3.org/2001/XMLSchema#string

Shankaran Kothandaraman

http://www.w3.org/2001/XMLSchema#string

P2860

Vandetanib for the treatment of medullary thyroid cancer

Upregulation of parathyroid VDR expression by extracellular calcium is mediated by ERK1/2-MAPK signaling pathway

N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity.

Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature.

Long-term efficacy of lymph node reoperation for persistent papillary thyroid cancer

Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.

A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism.

Extracellular calcium sensing and extracellular calcium signaling.

Integration of calcium and Ras signalling.

Endothelin receptor antagonists prevent parathyroid cell proliferation caused by hypocalcemia in rats.

P304

E1722-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2013-1756

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24030941

http://www.w3.org/2001/XMLSchema#string

P932

4326510

http://www.w3.org/2001/XMLSchema#string